← Leaderboards
Curtis Harris
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMolecularMalignant Neoplasm Of LungTumorMicrornasCellsTissuesPathway InteractionsBaseGenesPhenotypeCohortMessenger RnaTp53 GeneMutationDiagnosisCytokineInflammatoryMediatingCarcinogenesisCollaborationsSamplingOutcome ForecastColon Carcinoma
Grant awards (62)
Precision Medicine of Cancer$1,444,352
ZIA · FY2025 · CA · contact PI
p53, Aging, and Cancer$1,444,352
ZIA · FY2025 · CA · contact PI
p53, Aging, and Cancer$2,600,582
ZIA · FY2024 · CA · contact PI
Precision Medicine of Cancer$1,733,722
ZIA · FY2024 · CA · contact PI
Precision Medicine of Cancer$2,570,099
ZIA · FY2023 · CA · contact PI
p53, Aging, and Cancer$1,713,400
ZIA · FY2023 · CA · contact PI
Precision Medicine of Cancer$2,810,223
ZIA · FY2022 · CA · contact PI
p53, Aging, and Cancer$1,873,482
ZIA · FY2022 · CA · contact PI
Precision Medicine of Cancer$2,545,004
ZIA · FY2021 · CA · contact PI
p53, Aging, and Cancer$1,696,670
ZIA · FY2021 · CA · contact PI
p53, Aging, and Cancer$2,168,979
ZIA · FY2020 · CA · contact PI
Precision Medicine of Cancer$2,168,979
ZIA · FY2020 · CA · contact PI
p53, Aging, and Cancer$1,912,927
ZIA · FY2019 · CA · contact PI
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome$1,147,757
ZIA · FY2019 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$765,170
ZIA · FY2019 · CA · contact PI
p53, Aging, and Cancer$2,282,517
ZIA · FY2018 · CA · contact PI
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome$1,711,888
ZIA · FY2018 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,711,888
ZIA · FY2018 · CA · contact PI
p53, Aging, and Cancer$1,533,497
ZIA · FY2017 · CA · contact PI
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome$1,150,123
ZIA · FY2017 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,150,123
ZIA · FY2017 · CA · contact PI
p53, Aging, and Cancer$1,527,281
ZIA · FY2016 · CA · contact PI
Biomarkers in Cancer Diagnosis, Prognosis and Therapeutic Outcome$1,145,460
ZIA · FY2016 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,145,460
ZIA · FY2016 · CA · contact PI
Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome$1,585,226
ZIA · FY2015 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,585,226
ZIA · FY2015 · CA · contact PI
p53, Aging, and Cancer$792,614
ZIA · FY2015 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,586,024
ZIA · FY2014 · CA · contact PI
Biomarkers in Cancer Diagnosis,Prognosis, and Therapeutic Outcome$1,586,024
ZIA · FY2014 · CA · contact PI
p53, Aging, and Cancer$793,011
ZIA · FY2014 · CA · contact PI
Biomarkers in Cancer Diagnosis,Prognosis, and Therapuetic Outcome$1,604,436
ZIA · FY2013 · CA · contact PI
Integrative Molecular Epidemiology of Human Cancer$1,604,436
ZIA · FY2013 · CA · contact PI
p53, Aging, and Cancer$802,217
ZIA · FY2013 · CA · contact PI
p53 Tumor Suppressor Pathway$803,200
ZIA · FY2012 · CA · contact PI
Molecular Epidemiology of Human Lung Cancer$803,200
ZIA · FY2012 · CA · contact PI
Human Colon Cancer$803,200
ZIA · FY2012 · CA · contact PI
Biomarkers of Human Lung Cancer$803,200
ZIA · FY2012 · CA · contact PI
Inflammation and Cancer$803,200
ZIA · FY2012 · CA · contact PI
Molecular Epidemiology of Human Lung Cancer$644,202
ZIA · FY2011 · CA · contact PI
p53 Tumor Suppressor Pathway$644,202
ZIA · FY2011 · CA · contact PI
Human Colon Cancer$601,256
ZIA · FY2011 · CA · contact PI
Inhibitor of Normal Growth (ING)$601,256
ZIA · FY2011 · CA · contact PI
Biomarkers of Human Esophageal Cancer$601,256
ZIA · FY2011 · CA · contact PI
Biomarkers of Human Lung Cancer$601,256
ZIA · FY2011 · CA · contact PI
Inflammation and Cancer$601,256
ZIA · FY2011 · CA · contact PI
p53 Tumor Suppressor Pathway$793,889
ZIA · FY2010 · CA · contact PI
Molecular Epidemiology of Human Lung Cancer$793,889
ZIA · FY2010 · CA · contact PI
Human Colon Cancer$740,964
ZIA · FY2010 · CA · contact PI
Inflammation and Cancer$740,964
ZIA · FY2010 · CA · contact PI
Biomarkers of Human Lung Cancer$740,964
ZIA · FY2010 · CA · contact PI
Inhibitor of Normal Growth (ING)$740,964
ZIA · FY2010 · CA · contact PI
Biomarkers of Human Esophageal Cancer$740,964
ZIA · FY2010 · CA · contact PI
p53 Tumor Suppressor Pathway$786,156
ZIA · FY2009 · CA · contact PI
Molecular Epidemiology of Human Lung Cancer$786,156
ZIA · FY2009 · CA · contact PI
Biomarkers of Human Esophageal Cancer$733,746
ZIA · FY2009 · CA · contact PI
Biomarkers of Human Lung Cancer$733,746
ZIA · FY2009 · CA · contact PI
Inhibitor of Normal Growth (ING)$733,746
ZIA · FY2009 · CA · contact PI
Human Colon Cancer$733,746
ZIA · FY2009 · CA · contact PI
Inflammation and Cancer$733,746
ZIA · FY2009 · CA · contact PI
Biomarkers of Human Lung Cancer$735,101
Z01 · FY2008 · CA · contact PI
Human Colon Cancer$691,860
Z01 · FY2008 · CA · contact PI
Inhibitor of Normal Growth (ING)$648,619
Z01 · FY2008 · CA · contact PI